Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark P Lythgoe

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
The Lancet. Oncology|April 30, 2022
FDA decisions on new oncological drugsDavid J Benjamin, Vinay Prasad, Mark P Lythgoe
European Journal of Cancer (Oxford, England : 1990)|June 8, 2024
Access divergence to new cancer medicines in the United KingdomMark P Lythgoe, Sarah Blagden, Susannah Stanway, et al.
Journal of Cancer Policy|April 14, 2024
Implications of FDA's marketing authorization of hereditary cancer testingDavid J Benjamin, Mark P Lythgoe, Arash Rezazadeh Kalebasty
JCO Oncology Practice|January 16, 2024
Hollywood's Take on Oncology: Portrayal of Cancer in Movies, 2010-2020David J Benjamin, Mark P Lythgoe, Arash Rezazadeh Kalebasty
Cancers|August 27, 2021
Exploring the Epigenome in Gastroenteropancreatic Neuroendocrine NeoplasiasRohini Sharma, Mark P Lythgoe, Bhavandeep Slaich, et al.
JAMA Network Open|November 18, 2021
Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020Alyson Haslam, Mark P Lythgoe, Emma Greenstreet Akman, et al.
JAMA Network Open|March 15, 2022
Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016-2021David J Benjamin, Alexander Xu, Mark P Lythgoe, et al.
Familial Cancer|December 1, 2017
Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysisSalim S Malik, Mark P Lythgoe, Mark McPhail, et al.
Familial Cancer|February 17, 2018
Response to letter to editor regarding published article-metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysisMark P Lythgoe, Salim S Malik, Mark McPhail, et al.
Trends in Cancer|May 9, 2024
Lifileucel: the first cellular therapy approved for solid tumoursMax Julve, Mark P Lythgoe, James Larkin, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
The Lancet. Oncology|April 30, 2022
FDA decisions on new oncological drugsDavid J Benjamin, Vinay Prasad, Mark P Lythgoe
European Journal of Cancer (Oxford, England : 1990)|June 8, 2024
Access divergence to new cancer medicines in the United KingdomMark P Lythgoe, Sarah Blagden, Susannah Stanway, et al.
Journal of Cancer Policy|April 14, 2024
Implications of FDA's marketing authorization of hereditary cancer testingDavid J Benjamin, Mark P Lythgoe, Arash Rezazadeh Kalebasty
JCO Oncology Practice|January 16, 2024
Hollywood's Take on Oncology: Portrayal of Cancer in Movies, 2010-2020David J Benjamin, Mark P Lythgoe, Arash Rezazadeh Kalebasty
Cancers|August 27, 2021
Exploring the Epigenome in Gastroenteropancreatic Neuroendocrine NeoplasiasRohini Sharma, Mark P Lythgoe, Bhavandeep Slaich, et al.
JAMA Network Open|November 18, 2021
Characteristics of Cost-effectiveness Studies for Oncology Drugs Approved in the United States From 2015-2020Alyson Haslam, Mark P Lythgoe, Emma Greenstreet Akman, et al.
JAMA Network Open|March 15, 2022
Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016-2021David J Benjamin, Alexander Xu, Mark P Lythgoe, et al.
Familial Cancer|December 1, 2017
Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysisSalim S Malik, Mark P Lythgoe, Mark McPhail, et al.
Familial Cancer|February 17, 2018
Response to letter to editor regarding published article-metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysisMark P Lythgoe, Salim S Malik, Mark McPhail, et al.
Trends in Cancer|May 9, 2024
Lifileucel: the first cellular therapy approved for solid tumoursMax Julve, Mark P Lythgoe, James Larkin, et al.
Pageof 7